Vizioncore makes $500 donation to fight breast cancer

Vizioncore Inc. today announced the company is making a $500 donation to 26.2 with Donna - The National Marathon to Finish Breast Cancer. The charitable organization is the only U.S. marathon dedicated solely to raising funds to end breast cancer. Its third-annual marathon is scheduled for February 21 in Jacksonville Beach, FL.

“We congratulate all of the participants of the marathon and wish the organization the best of luck in securing donations to fight this deadly disease.”

The donation by Vizioncore was originally slated to be presented to a Vizioncore customer who won the Vizioncore Sweepstakes during the VMworld 2009 conference sponsored by VMware in September 2009. Since the winning customer was not able to accept the award due to its corporate policy, Vizioncore made the donation to 26.2 with Donna - The National Marathon to Finish Breast Cancer.

"We saw this as an opportunity to help a cause that's gaining national attention but still has a long way to go in the fight against breast cancer," said Vizioncore Director of Marketing Grace Krokidas. "We congratulate all of the participants of the marathon and wish the organization the best of luck in securing donations to fight this deadly disease."

SOURCE Vizioncore Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
City of Hope launches innovative national clinical trials model to expand access to cancer treatments